Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2002

View Archived Issues

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

Altocor approved for hypercholesterolemia, deemed approvable for CHD

AGY raises funds to advance CNS drug programs

Bay-58-2667, a novel sGC activator with potential in cardiovascular diseases

Merger of Pfizer and Pharmacia will create industry giant

S1P3 antagonists identified at U. of Virginia

New hypolipidemic agent acts through PPARalpha receptor activation

Invisible Condom generally well tolerated in phase I clinical study

Potent HIV integrase inhibitor successfully completes preclinical testing

Preclinical data suggest utility of alpha2-adrenoceptor antagonist in PD

Novel guanylate cyclase activators in the Bayer pipeline

Cell adhesion inhibitors identified by Kowa team

Tularik and Roche present novel IKK modulators

Merck patents alpha5-selective GABA-A modulators for cognition disorders

New CB2 agonists and their use in autoimmune diseases, etc.

Acarbose delays development of type 2 diabetes

Sanofi-Synthelabo claims new PARP inhibitors in recent patent

Dietary intake of vitamin C and E may lower the risk of Alzheimer's disease

Capecitabine + docetaxel improves survival in advanced breast cancer

Serine protease inhibitors with anticoagulant activity described by Pharmacia

Eupolauridine targets fungal topoisomerase II, not topoisomerase I

Hematopoietic stem cell gene therapy combined with nonmyeloblative conditioning in ADA-SCID

Atridox to be studied in chronic periodontitis/heart disease trial

Alimta expanded access program cleared for malignant pleural mesothelioma

GenVec and DirectGene collaborate to develop targeted cancer therapies

Aromasin approved in Japan for postmenopausal breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...